Vishwas H Devaiah, associate professor at Jindal Global Law School and executive director of the Centre for Intellectual Property Rights Studies, talks to Managing IP about the continuing evolution of ...

BioWorld - Thursday, August 22, 2024 See today's BioWorld Asia Home » India's first compulsory license stands; Bayer loses Nexavar appeal X Upgrade your daily dose of biopharma and medtech news ...

The Health Ministry in India has recommended that a compulsory licence (CL) is issued for the manufacture of Bristol-Myers Squibb’s (BMS) anti-cancer drug Sprycel (dasatinib), potentially opening the ...

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade ...